Dr William R Love

Lifelabs is a Canadian company offering a range of healthcare services, including personalized risk assessment for prostate cancer through their SelectMDx testing. This novel decision support tool provides important information to urologists to determine the likelihood of finding aggressive cancer upon biopsy.

With a focus on patient care and innovation, Lifelabs aims to provide individuals with valuable insights into their health, helping to guide treatment decisions and potentially avoid unnecessary procedures. Their SelectMDx test, which measures cancer-related genetic biomarkers, offers a high negative predictive value for clinically significant cancer, giving patients and healthcare providers additional tools for informed decision-making.

Generated from their website